KidneyCAN shared on X:
“Exciting research presented by Eddy Saad at KCRS24! A specific SNP in the IL7 gene can predict the risk of immune-related side effects from cancer treatments. This finding could help personalize and improve the safety of immune therapies for kidney cancer patients.”
Source: KidneyCAN/X